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The authors report the case of a 55 yr-old woman suffering from Crohn's disease since 31 years with stricture 
and fistulas developed in the ileocolic junction and anorectal portion. Long-standing anorectal fistulas and 
stricture led to adenocarcinoma and finally fistulisation in the vagina. Diagnosis was made by perineal 
examination with biopsies under general anaesthesia. Treatment was first posterior pelvectomy with resection of 
the anterior wall of vagina. Secondarily, radiochemotherapy was administrated. The authors discuss the 
incidence and risk factors of carcinoma in Crohn's disease with chronic fistulas. (Acta gastroenterol. belg., 2005, 
68, 98-100). 
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Introduction 
In contrast with ulcerative colitis where the risk of colorectal carcinoma is clearly established, this risk in 
Crohn's Disease (CD) remains controversial. Some studies reported increased comparative risk of colorectal 
carcinoma in individuals with CD (1-4), but to our knowledge few have been population based studies (5,6). 
This increased risk ranges from 2.1 to 20.0. The largest series were done by tertiary referral centres with 
selection bias. Some other studies, based on population, failed to demonstrate an increase in the incidence of any 
type of cancer, including colorectal cancer, in CD (7-9). Several investigators have noted the development of 
carcinoma at small bowel or large bowel fistula sites in CD (10-13) whereas carcinoma arising in anorectal 
fistula in the absence of CD occurs rarely (14). 
The authors herein describe the case of a woman with CD suffering of cancerisation of a rectovaginal fistula, and 
discuss the incidence and the risk factors of adenocarcinoma in CD with chronic fistulae. 
Case report 
The patient was a Caucasian woman born in 1949. She was diagnosed with CD in 1972 after development of 
abdominal pain and diarrhoea. Barium transit imagery showed CD located in ileum. She had no extra intestinal 
manifestation and no family history of inflammatory bowel disease. From 1972 to 1977 intermittent pain with 
diarrhoea persisted without complication. In 1977, she was operated on of an ileocolic resection for a sigmoido-
ileal fistula. Major symptoms were pain in the right lower quadrant, low grade fever, diarrhoea and weight loss. 
Histological examination of the 40 cm resected ileum confirmed CD despite absence of typical granuloma. From 
1972 to 1977 the patient was irregularly treated with sulfasalazine (Salazopyrine®, Pharmacia) or prednisolone 
(Deltacortril®, Pfizer). From 1977 to 1995, CD was stable with diarrhoea treated by colestyramine (Questran®, 
Bristol-Myers Squibb). In June 1995, the patient complained of bloody stools and anal pain exacerbated by 
defecation. Barium examination of the small bowel demonstrated CD recurrence on the last 30 cm of ileum and 
two short stenosis on this segment without any consequence on the transit. Proctologic examination was 
impossible because of the anal pain. Methylprednisolone (Medrol®, Pharmacia) was started at 16 mg/day and 
majored to 32mg/day with improvement of diarrhoea but exacerbation of anal pain. Proctologic examination was 
then performed under narcosis and showed two trans-sphincteric fistulae located under a rectal stenosis. Rectum 
was dilated and seemed to be normal above the stricture. The lowest fistula was opened and the second was 
drained with an elastic seton. In the post operative course, azathioprine (Imuran®, GSK) was started at 100 mg 
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per day and in 1997, methylprednisolone was progressively stopped and replaced by sulfasalazine. In 1997 the 
patient presented to the outpatient clinic with 3 diarrheic stools per day and good clinical status. The rectal 
diameter was evaluated to 1.5 cm and the seton was removed. The patient did not show up before 2003. In July 
2003, the patient came back with severe diarrhoea (15 per day), pelvic pain, anal pain, and bloody loss by anus 
and vagina. Pelvic magnetic resonance showed perirectal collections drained in vagina and rectum. 
Gynaecologic examination showed granulation tissue developed on a rectovaginal sinus. Histological sample 
suggested enteric adenocarcinoma. Proctologic examination was performed under narcosis with a new dilatation 
of the rectum and biopsies. No endoluminal tumour was found in the rectum. A total colonoscopy demonstrated 
only a fibrous zone ulcerated in its center at the place of the fistula above the stricture. No other lesion was 
described. Computed tomography of the abdomen and pelvis demonstrated a heterogeneous mass in the rectum 
wall with a collection drained in the vagina and in a blind ending fistula towards the sacrum. No metastatic 
disease was objectived by abdominal tomodensitography or thorax roentgenogram. Tumour markers were 
positive (CA 19-9: 113.5U/ml (normal value: 0-56.0); CEA : 16.8U/ml (normal value : 0-5.0). In September 
2003, the patient underwent a posterior pelvectomy with en bloc resection of uterus, annexa uteri and 
rectosigmoid colon. The total meso-rectal excision was performed and the anterior portion of the vaginal wall 
was resected. No metastatic disease was found intraperitonealy. Histological examination of the surgical 
specimen confirmed the presence of a colloidal pT4N0M0 enteric adenocarcinoma in the wall of the rectum 
infiltrating all the layers and the vaginal wall. The postoperative course was good and the patient was discharged 
on the 23rd day of hospitalisation because of long learning time for stomy management. A radio-chemotherapy 
was scheduled as adjuvant therapy. 
Discussion 
Historically, the first case of carcinoma associated with CD was reported in 1948 by Warren and Sommers (15). 
Since then, many reports suggested the association between CD and the developpement of carcinoma. The 
increased incidence of carcinoma of small bowel or colon in CD is still controversial but most studies 
demonstrated an increased comparative risk ranging from 2.1 to 20.0 (1-6). Three population based studies 
previously failed to demonstrate an increased incidence of any type of cancer, including colorectal cancer, in CD 
(7-9). In the three studies, the lack of association could be ascribed either to the small number of patient studies, 
the short duration of follow-up or the large proportion of patients receiving colectomy (1). 
Among these carcinomas, some developed on chronic fistula. Ky's personal serie demonstrated carcinoma 
related to fistula eight times in seven patients, seen during a 14-year period. It represents an incidence of 
approximatively 0.7 percent of CD patients (16).The overall incidence of anorectal fistulae associated with CD is 
between 20 an 25 percent when CD is limited to ileum, and increases to 60 percent when CD affects the rectum 
(16). 
Traube in 1980 identified risk factors that have been associated with adenocarcinoma in CD and confirmed the 
frequent association with fistulae (17). Most of those risk factors are positive in our case report (table 1). 
An increased risk of cancer in patient with CD had already been showed to be related to an early onset and a 
prolonged duration of the CD in 1973 (4). In our case, the age at which CD was diagnosed is 25 years, and the 
duration of CD before diagnosis of the carcinoma was 31 years. 
A review of the literature done by Alex Ky in 1998, concentrated all the reported cases of anorectal carcinoma 
associated with CD that could be related to anal fis tulas (16). The author reported 33 cases among which 15 
fistulas were clearly located (45%). In this review average duration of CD before carcinoma was 19.9 years. In 
the Ky's own series of 6 cases the average age at which CD was diagnosed is 25.6 years and the average duration 
of the disease before diagnosis of carcinoma was 14 years. Those two risk factors seem to be the same for 
development of cancer in colonic CD as for development of carcinoma in anorectal fistula in CD. 
Most colonic carcinomas in CD are poorly differentiated and mucinous compared with sporadic colon 
malignancies (18-20), and prognosis could be poorer (20). Relation between cancer and fistula is not known but 
some authors postulate that fistulas might lead to carcinoma because of the constant mucosal regeneration (16). 
Supporting this theory, some authors noted a strong association between high grade dysplasia and invasive 
adenocarcinoma in ileocolonic carcinoma in CD patient (18-21). Dysplasia adjacent to colorectal carcinoma has 
been reported in 83-100% of cases (18-20) while dysplasia distant from the cancer has been found in 23-70% 
(18,19,22). In contrast, only 2% of colectomy specimens of CD without carcinoma contained mild dysplasia 
(23). Because fistulas are frequently ulcerated, with chronic ulcerations or recurrent mucosal regeneration, this 
could lead to dysplastic changes that are precursors for malignant transformation. If this theory is supported by 
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further studies, the early recognition of fistula should lead to biopsies and brushing to reveal dysplasia in chronic 
fistula if their resection is not wished. 
 
Table 1. Risk Factors for carcinoma in CD 
Risk factors Case reported 
Onset of CD in 2nd or 3rd decade of life + 
Recrudescence of symptoms after an extended + 
asymptomatic period  
A 20- to 30-yr lag between diagnosis of CD and + 
diagnosis of carcinoma  
Fistula associated with near obstructing stricture + 
Bypassed segment of bowel - 
CD : Crohn's Disease. 
 
Many patient with anorectal lesions have few symptoms despite grossly distorted perianal anatomy. A recent 
change in symptoms may herald the onset of malignancy. The authors suggest then that patient with distal 
disease and chronic anal lesions should be monitored regularly for dysplasia or adenocarcinoma. Computed 
tomography and magnetic resonance examinations should be performed to analyse the situation. Concerning 
rectal ultrasound examination, this technique should probably be the best to diagnose carcinoma arising in fistula 
if rectal pain or stricture does not preclude the examination. A high degree of suspicion for carcinoma must be 
considered in CD suffering of chronic fistula. In those cases, as in our case, in which clinical or ultrasonographic 
examination is limited by pain or stricture, rectal examination under anaesthesia with biopsy, curettage or 
brushing of the fistulous tract is recommended. 
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